| Year |
Citation |
Score |
| 2024 |
Nair S, Sahay B, Arukha AP, Edison LK, Crews CD, Morris JG, Kariyawasam S, Yamamoto JK. Interferon-γ/IL-2 ELISpot and mRNA Responses to the SARS-CoV2, Feline Coronavirus Serotypes 1 (FCoV1), and FCoV2 Receptor Binding Domains by the T Cells from COVID-19-Vaccinated Humans and FCoV1-Infected Cats. Methods in Molecular Biology (Clifton, N.J.). 2768: 135-151. PMID 38502392 DOI: 10.1007/978-1-0716-3690-9_9 |
0.505 |
|
| 2023 |
Yamamoto JK, Edison LK, Rowe-Haas DK, Takano T, Gilor C, Crews CD, Tuanyok A, Arukha AP, Shiomitsu S, Walden HDS, Hohdatsu T, Tompkins SM, Morris JG, Sahay B, Kariyawasam S. Both Feline Coronavirus Serotypes 1 and 2 Infected Domestic Cats Develop Cross-Reactive Antibodies to SARS-CoV-2 Receptor Binding Domain: Its Implication to Pan-CoV Vaccine Development. Viruses. 15. PMID 37112894 DOI: 10.3390/v15040914 |
0.328 |
|
| 2019 |
Sahay B, Aranyos AM, Mishra M, McAvoy AC, Martin MM, Pu R, Shiomitsu S, Shiomitsu K, Dark MJ, Sanou MP, Roff SR, Rathore MH, Yamamoto JK. Immunogenicity and Efficacy of a Novel Multi-Antigenic Peptide Vaccine Based on Cross-Reactivity between Feline and Human Immunodeficiency Viruses. Viruses. 11. PMID 30717485 DOI: 10.3390/V11020136 |
0.805 |
|
| 2018 |
Sahay B, Aranyos AM, McAvoy A, Yamamoto JK. Utilization of Feline ELISpot to Evaluate the Immunogenicity of a T Cell-Based FIV MAP Vaccine. Methods in Molecular Biology (Clifton, N.J.). 1808: 197-219. PMID 29956186 DOI: 10.1007/978-1-4939-8567-8_18 |
0.635 |
|
| 2018 |
Sahay B, Yamamoto JK. Lessons Learned in Developing a Commercial FIV Vaccine: The Immunity Required for an Effective HIV-1 Vaccine. Viruses. 10. PMID 29789450 DOI: 10.3390/v10050277 |
0.621 |
|
| 2017 |
Sahay B, Nguyen CQ, Yamamoto JK. Conserved HIV Epitopes for an Effective HIV Vaccine. Journal of Clinical & Cellular Immunology. 8. PMID 29226015 DOI: 10.4172/2155-9899.1000518 |
0.609 |
|
| 2016 |
Aranyos AM, Roff SR, Pu R, Owen JL, Coleman JK, Yamamoto JK. An initial examination of the potential role of T-cell immunity in protection against feline immunodeficiency virus (FIV) infection. Vaccine. PMID 26802606 DOI: 10.1016/j.vaccine.2016.01.017 |
0.564 |
|
| 2016 |
Roff S, Sanou M, Aranyos A, Pu R, Rathore M, Levy J, Yamamoto J. P-C2 T-cell based lentiviral vaccines Jaids Journal of Acquired Immune Deficiency Syndromes. 71: 90. DOI: 10.1097/01.Qai.0000479726.27565.C4 |
0.802 |
|
| 2015 |
Roff SR, Sanou MP, Rathore MH, Levy JA, Yamamoto JK. Conserved epitopes on HIV-1, FIV and SIV p24 proteins are recognized by HIV-1 infected subjects. Human Vaccines & Immunotherapeutics. 11: 1540-56. PMID 25844718 DOI: 10.1080/21645515.2015.1026500 |
0.794 |
|
| 2014 |
Roff SR, Noon-Song EN, Yamamoto JK. The Significance of Interferon-γ in HIV-1 Pathogenesis, Therapy, and Prophylaxis. Frontiers in Immunology. 4: 498. PMID 24454311 DOI: 10.3389/fimmu.2013.00498 |
0.469 |
|
| 2014 |
Coleman JK, Pu R, Martin MM, Noon-Song EN, Zwijnenberg R, Yamamoto JK. Feline immunodeficiency virus (FIV) vaccine efficacy and FIV neutralizing antibodies. Vaccine. 32: 746-54. PMID 23800540 DOI: 10.1016/J.Vaccine.2013.05.024 |
0.828 |
|
| 2013 |
Sanou MP, Roff SR, Mennella A, Sleasman JW, Rathore MH, Yamamoto JK, Levy JA. Evolutionarily conserved epitopes on human immunodeficiency virus type 1 (HIV-1) and feline immunodeficiency virus reverse transcriptases detected by HIV-1-infected subjects. Journal of Virology. 87: 10004-15. PMID 23824804 DOI: 10.1128/Jvi.00359-13 |
0.794 |
|
| 2012 |
Sanou MP, De Groot AS, Murphey-Corb M, Levy JA, Yamamoto JK. HIV-1 Vaccine Trials: Evolving Concepts and Designs. The Open Aids Journal. 6: 274-88. PMID 23289052 DOI: 10.2174/1874613601206010274 |
0.84 |
|
| 2012 |
Abbott JR, Pu R, Coleman JK, Yamamoto JK. Utilization of feline ELISPOT for mapping vaccine epitopes. Methods in Molecular Biology (Clifton, N.J.). 792: 47-63. PMID 21956500 DOI: 10.1007/978-1-61779-325-7_4 |
0.696 |
|
| 2011 |
Abbott JR, Sanou MP, Coleman JK, Yamamoto JK. Evolutionarily conserved T-cell epitopes on FIV for designing an HIV/AIDS vaccine. Veterinary Immunology and Immunopathology. 143: 246-54. PMID 21719117 DOI: 10.1016/J.Vetimm.2011.06.019 |
0.845 |
|
| 2010 |
Yamamoto JK, Sanou MP, Abbott JR, Coleman JK. Feline immunodeficiency virus model for designing HIV/AIDS vaccines. Current Hiv Research. 8: 14-25. PMID 20210778 DOI: 10.2174/157016210790416361 |
0.831 |
|
| 2008 |
Uhl EW, Martin M, Coleman JK, Yamamoto JK. Advances in FIV vaccine technology. Veterinary Immunology and Immunopathology. 123: 65-80. PMID 18295907 DOI: 10.1016/J.Vetimm.2008.01.030 |
0.827 |
|
| 2007 |
Zwijnenberg R, Yamamoto JK. Vaccine protection against feline immunodeficiency virus: setting the challenge. Australian Veterinary Journal. 85: 210-1. PMID 17547630 DOI: 10.1111/j.1751-0813.2007.176_2.x |
0.516 |
|
| 2007 |
Yamamoto JK, Pu R, Sato E, Hohdatsu T. Feline immunodeficiency virus pathogenesis and development of a dual-subtype feline-immunodeficiency-virus vaccine. Aids (London, England). 21: 547-63. PMID 17314517 DOI: 10.1097/Qad.0B013E328013D88A |
0.522 |
|
| 2005 |
Coleman JK, Pu R, Martin M, Sato E, Yamamoto JK. HIV-1 p24 vaccine protects cats against feline immunodeficiency virus infection. Aids (London, England). 19: 1457-66. PMID 16135898 DOI: 10.1097/01.Aids.0000183627.81922.Be |
0.826 |
|
| 2005 |
Pu R, Coleman J, Coisman J, Sato E, Tanabe T, Arai M, Yamamoto JK. Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate. Journal of Feline Medicine and Surgery. 7: 65-70. PMID 15686976 DOI: 10.1016/J.Jfms.2004.08.005 |
0.522 |
|
| 2004 |
Omori M, Pu R, Tanabe T, Hou W, Coleman JK, Arai M, Yamamoto JK. Cellular immune responses to feline immunodeficiency virus (FIV) induced by dual-subtype FIV vaccine. Vaccine. 23: 386-98. PMID 15530685 DOI: 10.1016/J.Vaccine.2004.05.032 |
0.814 |
|
| 2002 |
Uhl EW, Heaton-Jones TG, Pu R, Yamamoto JK. FIV vaccine development and its importance to veterinary and human medicine: A review: FIV vaccine 2002 update and review Veterinary Immunology and Immunopathology. 90: 113-132. PMID 12459160 DOI: 10.1016/S0165-2427(02)00227-1 |
0.639 |
|
| 2001 |
Tanabe T, Yamamoto JK. Feline immunodeficiency virus lacks sensitivity to the antiviral activity of feline IFN-γ Journal of Interferon and Cytokine Research. 21: 1039-1046. PMID 11798461 DOI: 10.1089/107999001317205169 |
0.304 |
|
| 2001 |
Pu R, Coleman J, Omori M, Arai M, Hohdatsu T, Huang C, Tanabe T, Yamamoto JK. Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates. Aids (London, England). 15: 1225-37. PMID 11426067 DOI: 10.1097/00002030-200107060-00004 |
0.832 |
|
| 2001 |
Tanabe T, Yamamoto JK. Phenotypic and functional characteristics of FIV infection in the bone marrow stroma Virology. 282: 113-122. PMID 11259195 DOI: 10.1006/Viro.2000.0822 |
0.373 |
|
| 1999 |
Pu R, Omori M, Okada S, Rine SL, Lewis BA, Lipton E, Yamamoto JK. MHC-restricted protection of cats against FIV infection by adoptive transfer of immune cells from FIV-vaccinated donors. Cellular Immunology. 198: 30-43. PMID 10612649 DOI: 10.1006/Cimm.1999.1574 |
0.829 |
|
| 1999 |
Torres BA, Tanabe T, Subramaniam PS, Yamamoto JK, Johnson HM. Mechanism of HIV pathogenesis: Role of superantigens in disease Alcoholism: Clinical and Experimental Research. 23. DOI: 10.1111/J.1530-0277.1998.Tb03998.X |
0.478 |
|
| 1998 |
Tellier MC, Pu R, Pollock D, Vitsky A, Tartaglia J, Paoletti E, Yamamoto JK. Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats. Aids (London, England). 12: 11-8. PMID 9456250 DOI: 10.1097/00002030-199801000-00002 |
0.643 |
|
| 1997 |
Hohdatsu T, Okada S, Motokawa K, Aizawa C, Yamamoto JK, Koyama H. Effect of dual-subtype vaccine against feline immunodeficiency virus infection Veterinary Microbiology. 58: 155-165. PMID 9453127 DOI: 10.1016/S0378-1135(97)00164-8 |
0.633 |
|
| 1997 |
Elyar JS, Tellier MC, Soos JM, Yamamoto JK. Perspectives on FIV vaccine development. Vaccine. 15: 1437-44. PMID 9302758 DOI: 10.1016/S0264-410X(97)00056-X |
0.655 |
|
| 1997 |
Tellier MC, Soos J, Pu R, Pollock D, Yamamoto JK. Development of FIV-specific cytolytic T-lymphocyte responses in cats upon immunisation with FIV vaccines. Veterinary Microbiology. 57: 1-11. PMID 9231977 DOI: 10.1016/S0378-1135(97)00081-3 |
0.637 |
|
| 1997 |
Yamamoto J. Multi-subtype FIV vaccine Biofutur. 1997: 46. DOI: 10.1016/S0294-3506(99)80324-X |
0.598 |
|
| 1997 |
Torres B, Elyar JS, Okada S, Yamamoto JK. Fundamentals of FIV infection: Is a vaccine possible? Feline Practice. 25: 6-12. |
0.546 |
|
| 1996 |
Torres BA, Tanabe T, Yamamoto JK, Johnson HM. HIV encodes for its own CD4 T-cell superantigen mitogen Biochemical and Biophysical Research Communications. 225: 672-678. PMID 8753817 DOI: 10.1006/Bbrc.1996.1228 |
0.507 |
|
| 1996 |
Yamamoto JK, Tellier M, Pu R. Adoptive transfer of immunocytes from vaccinated cats confers MHC-restricted protection against FIV infection Faseb Journal. 10: A1082. |
0.485 |
|
| 1996 |
Torres BA, Tanabe, Yamamoto JK, Johnson HM. HIV encodes for its own cd4 t cell superantigen mitogeN Faseb Journal. 10: A1319. |
0.399 |
|
| 1995 |
Hosie MJ, Osborne R, Yamamoto JK, Neil JC, Jarrett O. Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines Journal of Virology. 69: 1253-1255. PMID 7815500 DOI: 10.1128/Jvi.69.2.1253-1255.1995 |
0.513 |
|
| 1995 |
Pu R, Okada S, Little ER, Xu B, Stoffs WV, Yamamoto JK. Protection of neonatal kittens against feline immunodeficiency virus infection with passive maternal antiviral antibodies Aids. 9: 235-242. PMID 7755911 DOI: 10.1097/00002030-199503000-00004 |
0.46 |
|
| 1994 |
Johnson CM, Torres BA, Koyama H, Yamamoto JK. Tenth anniversary perspectives on AIDS: FIV as a model for AIDS vaccination Aids Research and Human Retroviruses. 10: 225-228. PMID 8018382 DOI: 10.1089/Aid.1994.10.225 |
0.647 |
|
| 1994 |
Okada S, Pu R, Young E, Stoffs WV, Yamamoto JK. Superinfection of cats with feline immunodeficiency virus subtypes A and B Aids Research and Human Retroviruses. 10: 1739-1746. PMID 7888234 DOI: 10.1089/Aid.1994.10.1739 |
0.444 |
|
| 1993 |
Hohdatsu T, Pu R, Torres BA, Trujillo S, Gardner MB, Yamamoto JK. Passive antibody protection of cats against feline immunodeficiency virus infection Journal of Virology. 67: 2344-2348. PMID 8383246 DOI: 10.1128/Jvi.67.4.2344-2348.1993 |
0.609 |
|
| 1993 |
Yamamoto JK, Hohdatsu T, Olmsted RA, Pu R, Louie H, Zochlinski HA, Acevedo V, Johnson HM, Soulds GA, Gardner MB. Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus Journal of Virology. 67: 601-605. PMID 8380095 DOI: 10.1128/Jvi.67.1.601-605.1993 |
0.526 |
|
| 1992 |
Gardner M, Yamamoto J, Marthas M, Miller C, Jennings M, Rosenthal A, Luciw P, Planelles V, Yilma T, Giavedoni L, Ahmed S, Steimer K, Haigwood N, Pedersen N. SIV and FIV vaccine studies at UC Davis: 1991 update Aids Research and Human Retroviruses. 8: 1495-1498. PMID 1334682 DOI: 10.1089/Aid.1992.8.1495 |
0.603 |
|
| 1991 |
Yamamoto JK, Okuda T, Ackley CD, Louie H, Pembroke E, Zochlinski H, Munn RJ, Gardner MB. Experimental vaccine protection against feline immunodeficiency virus Aids Research and Human Retroviruses. 7: 911-922. PMID 1662057 DOI: 10.1089/Aid.1991.7.911 |
0.645 |
|
| 1991 |
Yamamoto JK, Ackley CD, Zochlinski H, Louie H, Pembroke E, Torten M, Hansen H, Munn R, Okud T. Development of il-2-independent feline lymphoid cell lines chronically infected with feline immunodeficiency virus: Importance for diagnostic reagents and vaccines Intervirology. 32: 361-375. PMID 1657826 DOI: 10.1159/000150220 |
0.474 |
|
| 1990 |
Ackley CD, Yamamoto JK, Levy N, Pedersen NC, Cooper MD. Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus Journal of Virology. 64: 5652-5655. PMID 1976826 DOI: 10.1128/Jvi.64.11.5652-5655.1990 |
0.341 |
|
| 1990 |
Jarrett O, Yamamoto JK, Neil JC. Feline immunodeficiency virus as a model for AIDS vaccination Aids. 4. PMID 1967108 DOI: 10.1097/00002030-199001001-00026 |
0.609 |
|
| 1989 |
Olmsted RA, Barnes AK, Yamamoto JK, Hirsch VM, Purcell RH, Johnson PR. Molecular cloning of feline immunodeficiency virus Proceedings of the National Academy of Sciences of the United States of America. 86: 2448-2452. PMID 2928341 DOI: 10.1073/Pnas.86.7.2448 |
0.405 |
|
| 1989 |
Sparger EE, Luciw PA, Elder JH, Yamamoto JK, Lowenstine LJ, Pedersen NC. Feline immunodeficiency virus is a lentivirus associated with an AIDS-like disease in cats Aids. 3. PMID 2558688 DOI: 10.1097/00002030-198901001-00006 |
0.315 |
|
| 1989 |
Pedersen NC, Yamamoto JK, Ishida T, Hansen H. Feline immunodeficiency virus infection Veterinary Immunology and Immunopathology. 21: 111-129. PMID 2549690 DOI: 10.1016/0165-2427(89)90134-7 |
0.337 |
|
| 1989 |
O'Connor TP, Tanguay S, Steinman R, Smith R, Barr MC, Yamamoto JK, Pedersen NC, Andersen PR, Tonelli QJ. Development and evaluation of immunoassay for detection of antibodies to the feline T-lymphotropic lentivirus (feline immunodeficiency virus). Journal of Clinical Microbiology. 27: 474-9. PMID 2541167 DOI: 10.1128/Jcm.27.3.474-479.1989 |
0.356 |
|
| 1987 |
Pedersen NC, Ho EW, Brown ML, Yamamoto JK. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome Science. 235: 790-793. PMID 3643650 DOI: 10.1126/Science.3643650 |
0.368 |
|
| 1985 |
Bryant ML, Yamamoto J, Luciw P, Munn R, Marx P, Higgins J, Pedersen N, Levine A, Gardner MB. Molecular comparison of retroviruses associated with human and simian AIDS. Hematological Oncology. 3: 187-97. PMID 2995224 DOI: 10.1002/Hon.2900030307 |
0.349 |
|
| Show low-probability matches. |